Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAT2 Genotyping for Isoniazid Re-challenge in TB Patients with Hepatitis
NCT02076685Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2007
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Open-label trial of isoniazid in Tuberculosis (TB), sponsored by National Taiwan University Hospital. Primary endpoint: Successful re-use of isoniazid for TB treatment at 6 months. Status: unknown.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02076685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076685.